Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMINI 1: Vuity for Presbyopia
NCT03804268Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Allergan. Started Dec 2018; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT03804268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804268.